HU0200337D0 - Stabilised pharmaceutical composition - Google Patents

Stabilised pharmaceutical composition

Info

Publication number
HU0200337D0
HU0200337D0 HU0200337A HUP0200337A HU0200337D0 HU 0200337 D0 HU0200337 D0 HU 0200337D0 HU 0200337 A HU0200337 A HU 0200337A HU P0200337 A HUP0200337 A HU P0200337A HU 0200337 D0 HU0200337 D0 HU 0200337D0
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
stabilised pharmaceutical
stabilised
composition
pharmaceutical
Prior art date
Application number
HU0200337A
Other languages
Hungarian (hu)
Inventor
Ujhelyi Gabriella Dr
Mathe Irma Kalmanne
Toth Antal Dr
Boglarka Jakab
Jozsef Vas
Marta Venczel
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Priority to HU0200337A priority Critical patent/HUP0200337A2/en
Publication of HU0200337D0 publication Critical patent/HU0200337D0/en
Priority to PCT/HU2003/000006 priority patent/WO2003063836A1/en
Publication of HUP0200337A2 publication Critical patent/HUP0200337A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
HU0200337A 2002-01-30 2002-01-30 Stabilised pharmaceutical composition comprising pravastatin sodium HUP0200337A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0200337A HUP0200337A2 (en) 2002-01-30 2002-01-30 Stabilised pharmaceutical composition comprising pravastatin sodium
PCT/HU2003/000006 WO2003063836A1 (en) 2002-01-30 2003-01-28 Stable pharmaceutical composition comprising pravastatin sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0200337A HUP0200337A2 (en) 2002-01-30 2002-01-30 Stabilised pharmaceutical composition comprising pravastatin sodium

Publications (2)

Publication Number Publication Date
HU0200337D0 true HU0200337D0 (en) 2002-03-28
HUP0200337A2 HUP0200337A2 (en) 2005-09-28

Family

ID=89980110

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200337A HUP0200337A2 (en) 2002-01-30 2002-01-30 Stabilised pharmaceutical composition comprising pravastatin sodium

Country Status (2)

Country Link
HU (1) HUP0200337A2 (en)
WO (1) WO2003063836A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation
KR101683635B1 (en) * 2014-12-29 2016-12-09 가천대학교 산학협력단 Pharmaceutical composition for treating cancer comprising lactate metallic salts
KR20200099172A (en) 2018-01-12 2020-08-21 (주) 메티메디제약 Methods of treating chronic inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000229855A (en) * 1998-12-07 2000-08-22 Satoshi Takebe Pravastatin sodium tablet
WO2001097800A1 (en) * 2000-06-23 2001-12-27 Sankyo Company, Limited Method of stabilizing medicinal compositions containing pravastatin

Also Published As

Publication number Publication date
HUP0200337A2 (en) 2005-09-28
WO2003063836A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
AU2003291103A8 (en) Pharmaceutical composition
GB0218625D0 (en) Pharmaceutical compounds
IL164547A0 (en) Pharmaceutical composition
GB2391473B (en) Pharmaceutical compositions
IL165878A0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
GB0215775D0 (en) Pharmaceutical compounds
EP1699458A4 (en) Pharmaceutical composition
GB0213481D0 (en) Pharmaceutical compositions
GB0300885D0 (en) Pharmaceutical composition
HK1081451A1 (en) Medicinal composition
HK1065477A1 (en) Pharmaceutical composition
GB0201520D0 (en) Pharmaceutical uses
GB0306933D0 (en) Pharmaceutical composition
HU0200337D0 (en) Stabilised pharmaceutical composition
HK1062274A1 (en) Medicinal composition
PL370907A1 (en) Pharmaceutical compositions
GB0307862D0 (en) Pharmaceutical composition
GB0217703D0 (en) Pharmaceutical composition
EP1547593A4 (en) Medicinal composition
GB0327389D0 (en) Stabilised pharmaceutical compositions
GB0213305D0 (en) Pharmaceutical composition
GB0220095D0 (en) Pharmaceutical composition
GB0211448D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees